(Total Views: 239)
Posted On: 03/15/2022 2:35:25 PM
Post# of 111
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
RedHill to receive $1.5 million upfront and is eligible for up to $5.6 million in milestone payments in addition to royalties on net sales from Kukbo
RedHill and Kukbo Enter Oral Opaganib License for COVID-19 in South Korea
https://www.redhillbio.com/news/news-details/...fault.aspx
RedHill and Kukbo Enter Oral Opaganib License for COVID-19 in South Korea
https://www.redhillbio.com/news/news-details/...fault.aspx
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)